Edgewise Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
EWTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1715 38 Th St, Boulder, CO

Insiders trading volume in the past year

Edgewise Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Novo Holdings A/S 10%+ Owner $95.8M Sep 14, 2022
Orbimed Advisors Llc Director, 10%+ Owner $8.93M +$10M Apr 3, 2025
Peter A. Thompson Director, 10%+ Owner $8.93M +$10M Jun 16, 2025
Kevin Koch President and CEO, Director $6.73M -$467K -6.49% Aug 12, 2025
R. Michael Carruthers Chief Financial Officer $1.59M -$40.7K -2.5% Aug 12, 2025
Russell Alan J Chief Scientific Officer, Director $932K -$6.64M -87.7% Nov 12, 2025
Robert Blaustein Chief Development Officer $821K Aug 12, 2025
Donovan Joanne M. Cmo $777K -$814K -51.2% Aug 12, 2025
Behrad Derakhshan Chief Business Officer $754K -$361K -32.4% Aug 12, 2025
Semigran Marc Chief Development Officer $639K -$882K -58% Dec 24, 2024
John R. Moore General Counsel $574K -$59.9K -9.44% Aug 12, 2025
Fox Jonathan C Director $442K +$199K +82.3% Nov 11, 2025
Christopher Nathan Martin Director Nov 19, 2025
Arlene Morris Director Jun 16, 2025
Jonathan D. Root Director Jun 16, 2025
Michael Nofi Chief Financial Officer Nov 10, 2025
Laura Brege Director Jun 16, 2025
Badreddin Edris Director Jun 16, 2025

Recent Insider Transactions by Companies or Individuals for Edgewise Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.